中国心血管健康与疾病报告2023概要

Report on Cardiovascular Health and Diseases in China 2023:an Updated Summary

自1990年以来,我国在解决心血管病(CVD)“救治难”的问题上已经取得了长足的进步。但由于我国居民不健康生活方式流行,有CVD危险因素的人群巨大,加之人口老龄化加速,CVD仍是我国居民健康的最大威胁之一。在我国城乡居民疾病死亡构成比中,CVD占首位,2021年分别占农村、城市死因的48.98%和47.35%;每5例死亡中就有2例死于CVD。为贯彻“以基层为重点,以预防为主”的国家方针,真正实现CVD防治主战场由医院逐步向社区转移,自2005年以来,国家心血管病中心每年组织全国相关领域的专家编撰《中国心血管健康与疾病报告》。以大样本横断面和队列人群流行病学调查、随机对照临床研究、大样本注册登记研究和社区防治典型案例等有代表性的、已发表的、高质量的研究结果为重点,今年的报告还纳入了国家心血管病中心承担的部分项目资料,这些一手数据丰富了报告内容,也更加及时、全面地反映了我国CVD防治的状况。

Since 1990,significant progress has been achieved on solving the problem of"treatment difficulty"of cardiovascular diseases(CVD)in China.There are huge population with CVD risk factors due to the prevalent unhealthy lifestyle among Chinese residents,this situation is further worsened due to accelerated aging of the population in China.CVD remains one of the greatest threats to the health of Chinese residents.In terms of proportions of disease mortality among urban and rural residents in China,CVD still ranks the first.In 2021,CVD accounted for 48.98%and 47.35%of deaths in rural and urban areas,respectively.Two out of every five deaths are due to CVD.In order to implement the national policy of"focusing on the primary health institute and emphasizing prevention"and truly achieve the shift of the CVD prevention and treatment from hospitals to communities,the National Center for Cardiovascular Diseases has organized experts from relevant fields across the country to compile the"Report on Cardiovascular Health and Diseases in China"annually since 2005.This year's report is established based on representative,published,and high-quality big-data research results from cross-sectional and cohort population epidemiological surveys,randomized controlled clinical studies,large sample registry studies,and typical community prevention and treatment cases,present report also includes data from some of the projects undertaken by the National Center for Cardiovascular Diseases.These first hand data not only enrich the content of the current report but also provide a more timely and comprehensive reflection of the status of CVD prevention and treatment in China.